
    
      This study will enroll 87 stroke patients who have been diagnosed with stroke and meet the
      inclusion criteria.

      After successfully meeting initial screening criteria, investigators will contact the family,
      explain the study, and send a consent form for their review.

      After that, patients will be given 0.5mg/day oral fingolimod over a course of 3 consecutive
      days , then investigators will make a neurofunctional assessment before and 7days, 30 days
      and 90days after oral fingolimod. And Magnetic Resonance of the brain before, 7days, 14days
      and 90days after oral fingolimod. Furthermore 5ml intravenous blood for flow cytometry is
      also taken before and 1day,3days,7days after fingolimod use.
    
  